Atlas Trials

Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

Clinical trial NCT06141031 · RECRUITING

Trial details

NCT number
NCT06141031
Sponsor
Washington University School of Medicine
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2024-01-16
Primary completion
2029-06-30
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.